Fr479 IN VIVO CHARACTERIZATION OF SER-301, AN INVESTIGATIONAL RATIONALLY-DESIGNED MICROBIOME THERAPEUTIC FOR PATIENTS WITH ACTIVE MILD-TO-MODERATE ULCERATIVE COLITIS
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI